Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Colorectal Cancer (CRC) & Group 3 ILCs (ILC3)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Colorectal Cancer (CRC) shows altered Group 3 ILCs (ILC3) (reduced frequencies, increased plasticity, imbalance with T cells). Mice lacking Group 3 ILCs (ILC3)-specific MHC-II develop invasive Colorectal Cancer (CRC) and resistance to anti-PD-1 immunotherapy
Goc et al. 2021 Cell 184:

References (Sources)

Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer
Goc et al. 2021 Cell 184:

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

Colorectal Cancer (CRC) & Group 3 ILCs (ILC3)

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat